Algorithm for Thorough Background Subtraction of High-Resolution LC/MS Data: Application to Obtain Clean Product Ion Spectra from Nonselective Collision-Induced Dissociation Experiments

被引:22
作者
Zhang, Haiying [1 ]
Grubb, Mary [1 ]
Wu, Wei [2 ]
Josephs, Jonathan [1 ]
Humphreys, William G. [1 ]
机构
[1] Bristol Myers Squibb Res & Dev, Biotransformation, Pennington, NJ 08534 USA
[2] Bristol Myers Squibb Res & Dev, Prot Therapeut Dev, Pennington, NJ 08534 USA
关键词
TANDEM MASS-SPECTROMETRY; HEAVY-METAL TOXICITY; METABOLITE IDENTIFICATION; DRUG-METABOLISM; ELECTROSPRAY-IONIZATION; STRUCTURE ELUCIDATION; IN-VITRO; BUSPIRONE; TRAP; INDINAVIR;
D O I
10.1021/ac8027189
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Nonselective collision-induced dissociation (CID) is a technique for producing fragmentation products for all ions generated in an ion source. It is typical of liquid chromatography/mass spectrometry (LC/MS) analysis of complex samples that matrix-related components may contribute to the resulting product ion spectra and confound the usefulness of this technique for structure interpretation. In this proof-of-principle study, a high-resolution LC/MS-based background subtraction algorithm was used to process the nonselective CID data to obtain clean product ion spectra for metabolites in human plasma samples. With buspirone and clozapine metabolites in human plasma as examples, this approach allowed for not only facile detection of metabolites of interest but also generation of their respective product ion spectra that were clean and free of matrix-related interferences. This was demonstrated with both an MS(E) technique (where E represents collision energy) with a quadrupole time-of-flight (QTOF) instrument and an in-source fragmentation technique with. an LTQ Orbitrap instrument. The combined nonselective CID and background subtraction approach should allow for detection and structural interpretation of other types of sample analyses where control samples are obtained.
引用
收藏
页码:2695 / 2700
页数:6
相关论文
共 36 条
[1]   Modern GC-MS technology in the forensic laboratory [J].
Aebi, B ;
Bernhard, W .
CHIMIA, 2002, 56 (03) :48-52
[2]   Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: Application to studies on the biotransformation of Indinavir [J].
Anari, MR ;
Sanchez, RI ;
Bakhtiar, R ;
Franklin, RB ;
Baillie, TA .
ANALYTICAL CHEMISTRY, 2004, 76 (03) :823-832
[3]   Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients. [J].
Aravagiri, M ;
Marder, SR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (02) :301-311
[4]   MASS-SPECTROMETRY IN THE ANALYSIS OF GLUTATHIONE CONJUGATES [J].
BAILLIE, TA ;
DAVIS, MR .
BIOLOGICAL MASS SPECTROMETRY, 1993, 22 (06) :319-325
[5]  
BARBER M, 1981, SOFT IONIZATION BIOL, P137
[6]   MSE with mass defect filtering for in vitro and in vivo metabolite identification [J].
Bateman, Kevin P. ;
Castro-Perez, Jose ;
Wrona, Mark ;
Shockcor, John P. ;
Yu, Kate ;
Oballa, Renata ;
Nicoll-Griffith, Deborah A. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2007, 21 (09) :1485-1496
[7]  
BILLER JE, 1974, ANAL LETT, V7, P515
[8]   Systematic LC/MS metabolite identification in drug discovery [J].
Clarke, N ;
Rindgen, D ;
Korfmacher, W ;
Cox, K .
ANALYTICAL CHEMISTRY, 2001, 73 (15) :430A-439A
[9]  
CLAYTON E, 2001, ADV MASS SPECTROM, V15, P403
[10]   Automated software-guided identification of new buspirone metabolites using capillary LC coupled to ion trap and TOF mass spectrometry [J].
Fandiño, AS ;
Nägele, E ;
Perkins, PD .
JOURNAL OF MASS SPECTROMETRY, 2006, 41 (02) :248-255